According to AlphaMoat, in October 2026 Immunai (immunai.com) received 4,329 monthly visits (-55.9% MoM) — ranked #12,724 of 17,609 AI websites with traffic data, and #2,069 of 3,112 in Industry Services; its largest market is United States (89.8% of visits).
Immunai partners with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics, founded in 2018, built around its AMICA data foundation that it has continued to expand through acquisitions.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-07 | 8.9K | — |
| 2026-08 | 13.5K | +52.7% |
| 2026-09 | 9.8K | -27.5% |
| 2026-10 | 4.3K | -55.9% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Immunai (immunai.com) received 4,329 visits (about 4.3K) in October 2026 (-55.9% month over month), ranking #12,724 of 17,609 AI websites with traffic data, and #2069 in Industry Services.
In October 2026, Immunai’s largest markets by share of visits are United States 89.8%, India 10.2%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.